We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Israel Chemicals (ICL) in Q1 Earnings?
Read MoreHide Full Article
Israel Chemicals Ltd. (ICL - Free Report) is slated to release first-quarter 2019 results before the bell on May 7. The company will likely gain from pricing strength across its businesses in the quarter.
Israel Chemicals’ shares are up around 11.8% over a year, outperforming the roughly 5.6% rise recorded by the industry.
Let’s see how things are shaping up for this announcement.
Factors to Consider
Israel Chemicals, in its fourth-quarter call, said that it will remain focused on optimizing its prices and driving margin expansion in 2019. Progress on streamlining its business is also expected to support results this year. The company has also secured several supply agreements for bromine compounds for this year, most of which are with higher prices and stable volumes.
Israel Chemicals gained from higher prices (especially for bromine) across its businesses in the last reported quarter. Higher prices across the bromine and phosphate value chains and increased realized prices for potash boosted its margins. Strict environmental-related regulatory pressure in China contributed to higher prices for bromine and phosphorous-based flame retardants. Potash prices also rose on the back of low availability of product for spot sales.
Pricing strength is expected to continue into the first quarter, lending support to the company sales and margins. However, the company is likely to continue to face higher raw material and transportation costs in the to-be-reported quarter.
Our proven model does not show that Israel Chemicals is likely to beat estimates this quarter. That is because a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below:
Earnings ESP: Earnings ESP for Israel Chemicals is 0.00%. This is because the Most Accurate Estimate and the Zacks Consensus Estimate both stand at 10 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Israel Chemicals carries a Zacks Rank #2, which when combined with a 0.00% ESP, makes surprise prediction difficult.
Note that we caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks That Warrant a Look
Here are some other companies in the basic materials space you may want to consider as our model shows they too have the right combination of elements to post an earnings beat this quarter:
Bunge Limited (BG - Free Report) has an Earnings ESP of +5.00% and carries a Zacks Rank #3.
Covia Holdings Corporation (CVIA - Free Report) has an Earnings ESP of +9.47% and carries a Zacks Rank #3.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
What's in Store for Israel Chemicals (ICL) in Q1 Earnings?
Israel Chemicals Ltd. (ICL - Free Report) is slated to release first-quarter 2019 results before the bell on May 7. The company will likely gain from pricing strength across its businesses in the quarter.
Israel Chemicals’ shares are up around 11.8% over a year, outperforming the roughly 5.6% rise recorded by the industry.
Let’s see how things are shaping up for this announcement.
Factors to Consider
Israel Chemicals, in its fourth-quarter call, said that it will remain focused on optimizing its prices and driving margin expansion in 2019. Progress on streamlining its business is also expected to support results this year. The company has also secured several supply agreements for bromine compounds for this year, most of which are with higher prices and stable volumes.
Israel Chemicals gained from higher prices (especially for bromine) across its businesses in the last reported quarter. Higher prices across the bromine and phosphate value chains and increased realized prices for potash boosted its margins. Strict environmental-related regulatory pressure in China contributed to higher prices for bromine and phosphorous-based flame retardants. Potash prices also rose on the back of low availability of product for spot sales.
Pricing strength is expected to continue into the first quarter, lending support to the company sales and margins. However, the company is likely to continue to face higher raw material and transportation costs in the to-be-reported quarter.
Israel Chemicals Shs Price and EPS Surprise
Israel Chemicals Shs price-eps-surprise | Israel Chemicals Shs Quote
What the Zacks Model Says
Our proven model does not show that Israel Chemicals is likely to beat estimates this quarter. That is because a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below:
Earnings ESP: Earnings ESP for Israel Chemicals is 0.00%. This is because the Most Accurate Estimate and the Zacks Consensus Estimate both stand at 10 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Israel Chemicals carries a Zacks Rank #2, which when combined with a 0.00% ESP, makes surprise prediction difficult.
Note that we caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks That Warrant a Look
Here are some other companies in the basic materials space you may want to consider as our model shows they too have the right combination of elements to post an earnings beat this quarter:
Intrepid Potash, Inc. (IPI - Free Report) has an Earnings ESP of +25.00% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Bunge Limited (BG - Free Report) has an Earnings ESP of +5.00% and carries a Zacks Rank #3.
Covia Holdings Corporation (CVIA - Free Report) has an Earnings ESP of +9.47% and carries a Zacks Rank #3.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>